{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:01:28Z","timestamp":1762639288280,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.xagr.2025.100497","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T23:08:41Z","timestamp":1743980921000},"page":"100497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Venous thromboembolism with contraceptive use in females with sickle cell trait"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1843-2982","authenticated-orcid":false,"given":"Angela K.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candy","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwar E.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Shet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Bevans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2023","series-title":"Data and statistics on sickle cell disease","key":"10.1016\/j.xagr.2025.100497_bib0001"},{"key":"10.1016\/j.xagr.2025.100497_bib0002","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3324\/haematol.2018.206060","article-title":"The carrier state for sickle cell disease is not completely harmless","volume":"104","author":"Xu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.xagr.2025.100497_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/jth.12787","article-title":"Prospective study of sickle cell trait and venous thromboembolism incidence","volume":"13","author":"Folsom","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.xagr.2025.100497_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12959-018-0179-z","article-title":"Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis","volume":"16","author":"Noubiap","year":"2018","journal-title":"Thromb J"},{"key":"10.1016\/j.xagr.2025.100497_bib0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.7326\/M18-1161","article-title":"Clinical outcomes associated with sickle cell trait: a systematic review","volume":"169","author":"Naik","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xagr.2025.100497_bib0006","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jth.15422","article-title":"An investigation of sickle cell trait, body mass index, and fitness in relation to venous thromboembolism among African American adults","volume":"19","author":"Nelson","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.xagr.2025.100497_bib0007","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/ijms24043169","article-title":"A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology","volume":"24","author":"Pastori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xagr.2025.100497_bib0008","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijgo.12455","article-title":"A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception","volume":"141","author":"Dragoman","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"year":"2017","series-title":"Combined hormonal contraception and the risk of venous thromboembolism: a guideline","key":"10.1016\/j.xagr.2025.100497_bib0009"},{"key":"10.1016\/j.xagr.2025.100497_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7304a1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2024","volume":"73","author":"Nguyen","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.xagr.2025.100497_bib0011","doi-asserted-by":"crossref","first-page":"620.e1","DOI":"10.1016\/j.ajog.2009.01.038","article-title":"Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women","volume":"200","author":"Austin","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100497_bib0012","first-page":"8","article-title":"Update: contraception among active component service women, U.S. Armed Forces 2017-2021","volume":"29","year":"2022","journal-title":"MSMR"},{"key":"10.1016\/j.xagr.2025.100497_bib0013","first-page":"47","article-title":"Contraceptive prescriptions for US servicewomen, 2008-2013","volume":"96","author":"Witkop","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.xagr.2025.100497_bib0014","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood-2016-07-727719","article-title":"Association among sickle cell trait, fitness, and cardiovascular risk factors in CARDIA","volume":"129","author":"Liem","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xagr.2025.100497_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.xagr.2025.100497_bib0016","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/jwh.2023.0735","article-title":"Racial disparities in highly effective contraceptive use among U.S. active duty servicewomen, fiscal years 2016-2019","volume":"33","author":"Barnhart","year":"2024","journal-title":"J Womens Health (Larchmt)"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:56:50Z","timestamp":1762639010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577825000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666577825000589"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100497","relation":{},"ISSN":["2666-5778"],"issn-type":[{"type":"print","value":"2666-5778"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Venous thromboembolism with contraceptive use in females with sickle cell trait","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100497"}}